• SIGN IN
  • GET HELP
  •  

    Home Study Details


    Program Type

    Home Study Webcast

    Credits

    1.5 Contact Hour(s)

    Release Date

    Friday, June 15, 2018

    Offline Date

    Saturday, December 15, 2018

    ACPE Expiration Date

    Friday, April 16, 2021

    Target Audience

    Pharmacist, Nurse

    Cost

    $0.00

    • Overview

      Asthma is a chronic obstructive respiratory disease that affects more than 300 million people world-wide and more than 25 million children and adults in the United States. Approximately 50% of patients with asthma struggle with "not well-controlled" or "poorly controlled" asthma. Around 10% of these patients have severe asthma and have an urgent need for improved care. Pharmacists can serve a critical role on the front lines of the health care community in the fight to get asthma under control. Pharmacists can education patients in areas from proper use of inhaler devices to reviewing treatment plans and explaining the evidence based efficacy data on new targeted therapies for severe asthma.

      Rating

         4.50  out of 5

      Handouts

      • Slide Document :   18047H01_4pp.pdf
      • Slide Document :   18047H01_2pp.pdf

      Financial Support By

      AstraZeneca
    • Pharmacist

      Evaluate evidence on the efficacy and safety of current and emerging targeted therapies for moderate-to-severe asthma
      Identify strategies for individualizing treatment and patient counseling for patients with severe asthma being treated with biologic therapy
      Outline the pathophysiologic features of severe asthma, including new insights into disease phenotypes and therapeutic targets for biologic medications
      Review the current guidelines for asthma treatment

      Nurse

      Evaluate evidence on the efficacy and safety of current and emerging targeted therapies for moderate-to-severe asthma
      Review the current guidelines for asthma treatment
      Outline the pathophysiologic features of severe asthma, including new insights into disease phenotypes and therapeutic targets for biologic medications
      Identify strategies for individualizing treatment and patient counseling for patients with severe asthma being treated with biologic therapy
    • Activity Type

      Knowledge

      CE Broker

      20-634965

      Universal Activity Number

      Pharmacist 0798-0000-18-047-H01-P
      Nurse 0798-0000-18-047-H01-P

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

    • Faculty

      Andria  Peterson, PharmD
      Assistant Professor, Roseman University & NICU/Pediatric Clinical Pharmacist, St. Rose Hospital

    HARDWARE REQUIREMENTS
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
     


    SOFTWARE REQUIREMENTS
    Microsoft Edge
    Internet Explorer 8.0 or higher
    Google Chrome
    Safari
    Firefox 3.0.3 or higher


    NETWORK REQUIREMENTS
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
     
     

    This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).